Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells
Top Cited Papers
Open Access
- 1 March 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 99 (5) , 1745-1757
- https://doi.org/10.1182/blood.v99.5.1745
Abstract
Bone marrow plasma cells (PCs) from 74 patients with newly diagnosed multiple myeloma (MM), 5 with monoclonal gammopathy of undetermined significance (MGUS), anKeywords
This publication has 53 references indexed in Scilit:
- High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISHBlood, 2000
- Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalitiesBlood, 2000
- Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridizationBlood, 2000
- Prognostic value of cytogenetics in multiple myelomaBritish Journal of Haematology, 1998
- Cytogenetic findings in 200 patients with multiple myelomaCancer Genetics and Cytogenetics, 1995
- Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma [see comments]Blood, 1993
- C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging systemBlood, 1992
- Value of beta 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myelomaBlood, 1988
- The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosisBlood, 1985
- Ploidy and proliferative characteristics in monoclonal gammopathiesBlood, 1982